MARKETSSTORY 686· JUNE 25, 2026

Chan Zuckerberg Initiative's Biohub Opens Rare Disease Grants and Expands AI Drug Repurposing Work With Every Cure

The Chan Zuckerberg Initiative's Biohub is opening a new funding round aimed at the rare disease community while simultaneously expanding its artificial intelligence drug repurposing partnership with Every Cure. The move signals a…

NDNewsDialy Desk2 MIN READ

SOURCE

cnbc.com

← PREVIOUS STORY 685CDC's Vaccine Advisory Panel Gets a New Charter That Widens the Door on Membership and Mission NEXT STORY 687 →Alan Greenspan, Federal Reserve Chairman for Nearly Two Decades, Dies at 100

Keep reading

More from the desk.

40MARKETS

Nvidia reportedly plans a $500 billion off-balance sheet vehicle

A half-trillion-dollar corporate structure designed to sit outside a company's main financial filings is reportedly being prepared for disclosure. That arrangement relies on a special purpose vehicle, a separate legal entity set up so its…

markets2 MIN

44MARKETS

AI share sales by Google and Intel leave the sector watching for the next move

Shares in AI-focused companies are being sold, and the market now wants to know who acts next. That kind of sale is called a divestiture, which means offloading a position you already own. Google (GOOGL) and Intel (INTC) have each made…

markets2 MIN

169MARKETS

Consensus positions took a hit in July, Goldman Sachs hedge fund desk says the volatility has passed

July rattled consensus market positions, the trades so widely held across funds that they function as the investing crowd's shared default bet. Goldman Sachs' head of hedge fund coverage told clients that the volatility responsible for…

markets2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk